Boothbay Fund Management, LLC Iveric Bio, Inc. Call Options Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	BUY	$18.67 - $24.56 $10.7 Million - $14.1 Million	572,200 Added 819.77%	642,000 $15.6 Million
Q4 2022 Feb 14, 2023	SELL	$17.24 - $23.95 $41,375 - $57,480	-2,400 Reduced 3.32%	69,800 $1.49 Million
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $385,400 - $762,190	41,000 Added 131.41%	72,200 $1.3 Million
Q2 2022 Aug 15, 2022	BUY	$9.12 - $18.9 $284,544 - $589,680	31,200 New	31,200 $300,000
Q4 2021 Feb 14, 2022	SELL	$13.83 - $18.78 $275,217 - $373,722	-19,900 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.07 - $17.5 $140,693 - $348,250	19,900 New	19,900 $323,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.